Asset Details
Do you wish to reserve the book?
166 Identifying the financial costs of anticipatory medication prescriptions: A retrospective observational study using general practitioner and community nursing records
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
166 Identifying the financial costs of anticipatory medication prescriptions: A retrospective observational study using general practitioner and community nursing records
Do you wish to request the book?
166 Identifying the financial costs of anticipatory medication prescriptions: A retrospective observational study using general practitioner and community nursing records
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
166 Identifying the financial costs of anticipatory medication prescriptions: A retrospective observational study using general practitioner and community nursing records
2023
Overview
BackgroundThe prescribing of injectable end-of-life anticipatory medications ahead of possible need is recommended practice. The financial costs of anticipatory medication remain unknown.AimsTo identify the prescription, usage and wastage costs of anticipatory medications dispensed to patients living at home and in residential care.DesignRetrospective observational study using general practitioner and community nursing records.Data CollectionData were collected from eleven general practitioner practices using the records of the last 30 most recent deaths per practice. Patients were aged 18+ and died between 2017–2019 from any cause except trauma, sudden death or suicide.AnalysisAnticipatory medications were prescribed to 167/329 patients, of which 164 were included in the analysis. Costs were analysed at both patient-level and drug-level using univariate and multivariate quantitative analysis.ResultsMedian anticipatory prescription cost was £43.17 (IQR: £38.98-£60.47, range £8.76 to £229.82). Median administration prescription cost was £2.16 (IQR: £0.00-£12.09, range £0.00 to £83.14). Median wastage was £41.47 (IQR: £29.15-£54.33, range £0.00 to £195.36). Prescription, usage and wastage costs were significantly higher for patients prescribed an anticipatory syringe driver. There were wide variations in the wastage costs of individual drugs; Haloperidol and Cyclizine contributed 49% of the total wastage costs.ConclusionThe prescription and wastage costs of anticipatory medications are higher than previously estimated but remain modest. Usage of prescriptions is lower than previously expected. There may be scope to reduce the quantity of drug vials that are routinely prescribed without adversely affecting care; prospective clinical trials are needed to explore this possibility.
Publisher
British Medical Journal Publishing Group,BMJ Publishing Group LTD
